We report on p27 and cyclin E immunoreactivity (IR) in 86 patients with myelodysplastic syndromes (MDS). No association was found between cyclin E IR and survival in the whole series. Cyclin E IR was more prevalent in patients with refractory anemia (RA) and RA with ringed sideroblasts (RARS) with poor survival, although this trend was not statistically significant.

The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes / G. Pruneri, N. Fracchiolla, A. Cortelezzi, M. Ponzoni, P. Maisonneuve, G. Lambertenghi Deliliers. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 88:1(2003 Jan), pp. 109-110.

The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes

G. Pruneri;A. Cortelezzi;G. Lambertenghi Deliliers
2003-01

Abstract

We report on p27 and cyclin E immunoreactivity (IR) in 86 patients with myelodysplastic syndromes (MDS). No association was found between cyclin E IR and survival in the whole series. Cyclin E IR was more prevalent in patients with refractory anemia (RA) and RA with ringed sideroblasts (RARS) with poor survival, although this trend was not statistically significant.
Cyclin E; Myelodysplasyic syndromes; p27
Settore MED/15 - Malattie del Sangue
http://www.haematologica.org/2003_01/88109.htm
Article (author)
File in questo prodotto:
File Dimensione Formato  
109.full.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 84.17 kB
Formato Adobe PDF
84.17 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/47982
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact